Molina-Molina, M.
Machahua-Huamani, C.
Vicens-Zygmunt, V.
Llatjós, R.
Escobar, I.
Sala-Llinas, E.
Luburich-Hernaiz, P.
Dorca, J.
Montes-Worboys, A.
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS PI15/00710)
F. Hoffmann-La Roche
Article History
Received: 19 October 2017
Accepted: 16 April 2018
First Online: 27 April 2018
Ethic approval and consent to participate
: All human tissues were procured and managed in accordance with the Declaration of Helsinki, and the study was approved by the ethics committee of Bellvitge University Hospital (Hospitalet de Llobregat, Barcelona, Spain). Written informed consent was obtained from all subjects before recruitment.
: Hoffmann-La Roche supported this work by providing pirfenidone and part of research founding. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.